Supplementary Information

Transkrypt

1 Supplementary Information ovel -alkyl derivatives of naringenin and their oximes with antimicrobial and anticancer activity Joanna Kozłowska 1,*, Ewa Grela 2, Dagmara Baczyńska 3, Agnieszka Grabowiecka 2, Mirosław Anioł 1 1 Department of Chemistry, Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, orwida 25, Wrocław, 2 Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology, Wybrzeże Wyspiańskiego 27, Wrocław, Poland 3 Department of Molecular and Cellular Biology, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Borowska 211A, Wrocław, Poland Fig S1. 1 H-MR (600 MHz, CDCl3) spectrum of 7--Propylnaringenin (7a)

2 Fig S2. 13 C-MR (150 MHz, CDCl3) spectrum of 7--Propylnaringenin (7a) Fig S3. 1 H-MR (600 MHz, CDCl3) spectrum of 7,4 -Di--propylnaringenin (8a)

3 Fig S4. 13 C-MR (150 MHz, CDCl3) spectrum of 7,4 -Di--propylnaringenin (8a) Fig S5. 1 H-MR (600 MHz, CDCl3) spectrum of 5,7,4 -Tri--propylnaringenin (9a)

4 Fig S6. 13 C-MR (150 MHz, CDCl3) spectrum of 5,7,4 -Tri--propylnaringenin (9a) Fig S7. 1 H-MR (600 MHz, CDCl3) spectrum of 7--Isopropylnaringenin (10a)

5 Fig S8. 13 C-MR (150 MHz, CDCl3) spectrum of 7--Isopropylnaringenin (10a) Fig S9. 1 H-MR (600 MHz, CDCl3) spectrum of 7,4 -Di--isopropylnaringenin (11a)

6 Fig S C-MR (150 MHz, CDCl3) spectrum of 7,4 -Di--isopropylnaringenin (11a) Fig S11. 1 H-MR (600 MHz, CDCl3) spectrum of 7--Butylnaringenin (12a)

7 Fig S C-MR (150 MHz, CDCl3) spectrum of 7--Butylnaringenin (12a) Fig S13. 1 H-MR (600 MHz, CDCl3) spectrum of 7,4 -Di--butylnaringenin (13a)

8 Fig S C-MR (150 MHz, CDCl3) spectrum of 7,4 -Di--butylnaringenin (13a) Fig S15. 1 H-MR (600 MHz, CDCl3) spectrum of 7--Decylnaringenin (16a)

9 Fig S C-MR (150 MHz, CDCl3) spectrum of 7--Decylnaringenin (16a) Fig S17. 1 H-MR (600 MHz, CDCl3) spectrum of 7,4 -Di--decylnaringenin (17a)

10 Fig S C-MR (150 MHz, CDCl3) spectrum of 7,4 -Di--decylnaringenin (17a) Fig S19. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7--Propylnaringenin oxime (7b)

11 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7--Propylnaringenin oxime (7b) Fig S21. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7,4 -Di--propylnaringenin oxime (8b)

12 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7,4 -Di--propylnaringenin oxime (8b) Fig S23. 1 H-MR (600 MHz, (CD3)2S) spectrum of 5,7,4 -Tri--propylnaringenin oxime (9b)

13 Fig S C-MR (150 MHz, (CD3)2S) spectrum of 5,7,4 -Tri--propylnaringenin oxime (9b) Fig S25. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7--Isopropylnaringenin oxime (10b)

14 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7--Isopropylnaringenin oxime (10b) Fig S27. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7,4 -Di--isopropylnaringenin oxime (11b)

15 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7,4 -Di--isopropylnaringenin oxime (11b) Fig S29. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7--Butylnaringenin oxime (12b)

16 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7--Butylnaringenin oxime (12b) Fig S31. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7,4 -Di--butylnaringenin oxime (13b)

17 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7,4 -Di--butylnaringenin oxime (13b) Fig S33. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7--Decylnaringenin oxime (16b)

18 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7--Decylnaringenin oxime (16b) Fig S35. 1 H-MR (600 MHz, (CD3)2C) spectrum of 7,4 -Di--decylnaringenin oxime (17b)

19 Fig S C-MR (150 MHz, (CD3)2C) spectrum of 7,4 -Di--decylnaringenin oxime (17b)